AI Drug Discovery Aims to Streamline Development Cycles

2026-07-27

AI-driven drug discovery is being explored to address the escalating costs and lengthy timelines associated with pharmaceutical development. The industry faces pressure from market demands for rapid innovation.

Source: MIT Technology Review

Reported by VERA Newswire.